พบ "Public health policy"ทั้งหมด 1,322 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
ความเกี่ยวข้อง
ขอแสดงความยินดีกับนายแพทย์สุวิทย์ วิบุลผลประเสริฐ ที่ได้รับรางวัล Award for the Heroes of Public Health (วีรบุรุษสาธารณสุข) ประจําปี ค.ศ. 2023
ขอแสดงความยินดีกับ นายแพทย์สุวิทย์ วิบุลผลประเสริฐ รองประธานคณะกรรมการมูลนิธิเพื่อการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ และที่ปรึกษาสํานักงานปลัดกระทรวงสาธารณสุข (ด้านการต่างประเทศ) ที่ได้รับรางวัล Award for the Heroes of Public Health (วีรบุรุษสาธารณสุข) ประจําปี ค.ศ. 2023 ในฐานะผู้มีผลงานโดดเด่น
More Young Adults Have Insurance After Health Care Law, Study Says
Copies of the divisive 2010 Affordable Care Act, President Obama’s health care overhaul, in the office of Mitch McConnell, the Senate Republican leader, and at the headquarters of Families USA, an advocacy group that supported it. A provision allowing young adults to stay on their parents’ policies
General health check-ups ‘offer no benefit’
From Health news. BBC (http://www.bbc.co.uk/news/health-19964600)Visiting a doctor for a general check-up is unlikely to lead to a condition needing treatment being identified, but may cause undue stress, say experts.The Danish researchers that carried out the latest review, which involved more than
India to establish Medical Technology Assessment Board
Rhythma Kaul / Hindustand TimesNew Delhi: India announced the setting up of a Medical Technology Assessment Board (MTAB) that will be one-stop shop to review standards for medicines, vaccines, devices and insurance.The Board’s recommendations will be the last word for health policies and healthcare
Pay-for-performance in resource-constrained settings: Lessons learned from Thailand’s Quality and Outcomes Framework (2016)
Abstract
Introduction.
Many countries have introduced pay-for-performance (P4P) models to encourage health providers and institutions to provide good quality of care. In 2013, the National Health Security Office of Thailand introduced P4P, based on the UK Quality and Outcomes Framework (QOF),
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Abstract
Background and Objectives
The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Abstract
Background and Objectives
The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
Dispelling the myths of providing dialysis in low- and middle-income countries
Public policy for kidney replacement therapy eludes most low- and middle-income countries owing to the seemingly low number of cases and high cost. Countries such as Thailand have shown that public health authorities can effectively provide treatment and elevate health care for populations by overco
How can we make better health decisions: a Best Buy for all?
Abstract
The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) requires them to prioritize health spending. Prioritizing is even more important as low- and middle-income countries transition from external aid. Countries w
10 / หน้า